AI-powered drug company spun out of Google’s DeepMind says human trials are ‘very close’ After years of development, Isomorphic Labs says its AI-created drugs are nearly ready for human trials.

A secretive, Google-backed lab is using artificial intelligence to invent new medicines for humanity's worst illnesses. But can we trust drugs designed by a mind that isn't human?

Traditionally, drug discovery relied heavily on trial and error, with long timelines and high costs. The introduction of ...

In April, 2025, Demis Hassabis, the Nobel Prize-winning CEO of Google DeepMind, appeared on the US television show 60 Minutes and suggested that all diseases could be curable with the help of ...

Google DeepMind is getting ready to begin human testing of drugs developed using artificial intelligence. All you need to know ...

Isomorphic Labs, a drug discovery company spun out of Google DeepMind, is about to make a historic ... the company is close to achieving a major milestone by putting AI-designed drugs into human ...

A New Era of Research with Health Studio Clinical trials are the backbone of medical advancement but they’ve historically ...

Isomorphic Labs, a subsidiary of Alphabet Inc., is close to human trials for its AI-designed medicines. Other companies are also racing to use AI in drug discovery.

Overall, just 1 out of 10 drug candidates that gets through animal testing succeeds all the way through clinical trials and gains regulatory approval. AI is helping close the translational gap.

Google DeepMind is now unleashing the local model as a standalone VLA, and it's surprisingly robust. The new Gemini Robotics On-Device model is only a little less accurate than the hybrid version.